SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eun-A Kim, Chang Hun Cho, Soo Young Choi, Jee-Yin Ahn, Seung-Ju Yang, Sung-Woo Cho, 2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride alters lipopolysaccharide-induced proinflammatory cytokines and neuronal morphology in mouse fetal brain, Neuropharmacology, 2016, 102, 32

    CrossRef

  2. 2
    Valerio Chiurchiù, Antonio Orlacchio, Mauro Maccarrone, Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases, Oxidative Medicine and Cellular Longevity, 2016, 2016, 1

    CrossRef

  3. 3
    Abigail DeLoach, Michael Cozart, Arianna Kiaei, Mahmoud Kiaei, A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies, Expert Opinion on Drug Discovery, 2015, 10, 10, 1099

    CrossRef

  4. 4
    E.-A. Kim, C. H. Cho, D. W. Kim, S. Y. Choi, J.-W. Huh, S.-W. Cho, Antioxidative effects of ethyl 2-(3-(benzo[d]thiazol-2-yl)ureido)acetate against amyloid β-induced oxidative cell death via NF-κB, GSK-3β and β-catenin signaling pathways in cultured cortical neurons, Free Radical Research, 2015, 49, 4, 411

    CrossRef

  5. 5
    Eun-A Kim, Jiyoung Choi, A. Reum Han, Chang Hun Cho, Soo Young Choi, Jee-Yin Ahn, Sung-Woo Cho, 2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling, Journal of Neuroimmune Pharmacology, 2014, 9, 4, 461

    CrossRef

  6. 6
    Eun-A Kim, Chang Hun Cho, Hoh-Gyu Hahn, Soo Young Choi, Sung-Woo Cho, 2-Cyclopropylimino-3-methyl-1,3-thiazoline Hydrochloride Protects Against Beta-amyloid-induced Activation of the Apoptotic Cascade in Cultured Cortical Neurons, Cellular and Molecular Neurobiology, 2014, 34, 7, 963

    CrossRef

  7. 7
    Eun-A Kim, A Reum Han, Jiyoung Choi, Jee-Yin Ahn, Soo Young Choi, Sung-Woo Cho, Anti-inflammatory mechanisms of N-adamantyl-4-methylthiazol-2-amine in lipopolysaccharide-stimulated BV-2 microglial cells, International Immunopharmacology, 2014, 22, 1, 73

    CrossRef

  8. 8
    Dong Wei, Chichih Wu, Ping He, Doug Kerr, Scott Stecher, Liyu Yang, Chiral liquid chromatography–tandem mass spectrometry assay to determine that dexpramipexole is not converted to pramipexole in vivo after administered in humans, Journal of Chromatography B, 2014, 971, 133

    CrossRef

  9. 9
    Ping He, Doug Kerr, Thomas Marbury, Daniel Ries, Wildon Farwell, Scott Stecher, Yingwen Dong, Dong Wei, Mark Rogge, Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function, The Journal of Clinical Pharmacology, 2014, 54, 12
  10. 10
    Yin M. Yang, Shailesh K. Gupta, Kevin J. Kim, Berit E. Powers, Antonio Cerqueira, Brian J. Wainger, Hien D. Ngo, Kathryn A. Rosowski, Pamela A. Schein, Courtney A. Ackeifi, Anthony C. Arvanites, Lance S. Davidow, Clifford J. Woolf, Lee L. Rubin, A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS, Cell Stem Cell, 2013, 12, 6, 713

    CrossRef

  11. 11
    Lucie Ayach, Christophe Curti, Marc Montana, Pascale Pisano, Patrice Vanelle, Actualités dans le traitement étiologique de la sclérose latérale amyotrophique, Thérapie, 2013, 68, 2, 93

    CrossRef

  12. 12
    Santiago Cuevas, Van Villar, Pedro Jose, Ines Armando, Renal Dopamine Receptors, Oxidative Stress, and Hypertension, International Journal of Molecular Sciences, 2013, 14, 9, 17553

    CrossRef

  13. 13
    Philip McGoldrick, Peter I. Joyce, Elizabeth M.C. Fisher, Linda Greensmith, Rodent models of amyotrophic lateral sclerosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 9, 1421

    CrossRef

  14. 14
    Rachna S. Pandya, Haining Zhu, Wei Li, Robert Bowser, Robert M. Friedlander, Xin Wang, Therapeutic neuroprotective agents for amyotrophic lateral sclerosis, Cellular and Molecular Life Sciences, 2013, 70, 24, 4729

    CrossRef

  15. 15
    Pedro A. Jose, Robin A. Felder, Gilbert M. Eisner, Seldin and Giebisch's The Kidney, 2013,

    CrossRef

  16. 16
    Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt, Péter Mátyus, Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis, Expert Opinion on Investigational Drugs, 2012, 21, 9, 1267

    CrossRef

  17. 17
    Ümide Demir Özkay, Özgür Devrim Can, Yusuf Özkay, Yusuf Öztürk, Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits, Pharmacological Reports, 2012, 64, 4, 834

    CrossRef

  18. 18
    Kambiz N. Alavian, Steven I. Dworetzky, Laura Bonanni, Ping Zhang, Silvio Sacchetti, Maria A. Mariggio, Marco Onofrj, Astrid Thomas, Hongmei Li, Jamie E. Mangold, Armando P. Signore, Ulrike DeMarco, Damon R. Demady, Panah Nabili, Emma Lazrove, Peter J.S. Smith, Valentin K. Gribkoff, Elizabeth A. Jonas, Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency, Brain Research, 2012, 1446, 1

    CrossRef

  19. 19
    Ana G. Neo, Rosa M. Carrillo, Carlos F. Marcos, A straightforward synthesis of 2-aminobenzothiazoles from Herz compounds, Organic & Biomolecular Chemistry, 2011, 9, 13, 4850

    CrossRef

  20. 20
    Valerio Chiurchiù, Mauro Maccarrone, Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities, Antioxidants & Redox Signaling, 2011, 15, 9, 2605

    CrossRef

  21. 21
    Lorne Zinman, Merit Cudkowicz, Emerging targets and treatments in amyotrophic lateral sclerosis, The Lancet Neurology, 2011, 10, 5, 481

    CrossRef

  22. 22
    Magali Dumont, M. Flint Beal, Neuroprotective strategies involving ROS in Alzheimer disease, Free Radical Biology and Medicine, 2011, 51, 5, 1014

    CrossRef

  23. 23
    Joong Hee Kim, Tzy-Haw Wu, Matthew D. Budde, Jin-Moo Lee, Sheng-Kwei Song, Noninvasive detection of brainstem and spinal cord axonal degeneration in an amyotrophic lateral sclerosis mouse model, NMR in Biomedicine, 2011, 24, 2
  24. 24
    Michael E. Bozik, James L. Mather, William G. Kramer, Valentin K. Gribkoff, Evan W. Ingersoll, Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects, The Journal of Clinical Pharmacology, 2011, 51, 8
  25. 25
    Peter I. Joyce, Pietro Fratta, Elizabeth M. C. Fisher, Abraham Acevedo-Arozena, SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments, Mammalian Genome, 2011, 22, 7-8, 420

    CrossRef

  26. 26
    Merit Cudkowicz, Michael E Bozik, Evan W Ingersoll, Robert Miller, Hiroshi Mitsumoto, Jeremy Shefner, Dan H Moore, David Schoenfeld, James L Mather, Donald Archibald, Mary Sullivan, Craig Amburgey, Juliet Moritz, Valentin K Gribkoff, The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis, Nature Medicine, 2011, 17, 12, 1652

    CrossRef

  27. 27
    Richard S Bedlack, Amyotrophic lateral sclerosis: current practice and future treatments, Current Opinion in Neurology, 2010, 23, 5, 524

    CrossRef

  28. 28
    Beatrice Nefussy, Vivian E. Drory, Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies, EPMA Journal, 2010, 1, 2, 329

    CrossRef

  29. 29
    Siân C. Barber, Pamela J. Shaw, Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target, Free Radical Biology and Medicine, 2010, 48, 5, 629

    CrossRef

  30. 30
    Barrie J. Carter, Pervin Anklesaria, Stephanie Choi, John F. Engelhardt, Redox Modifier Genes and Pathways in Amyotrophic Lateral Sclerosis, Antioxidants & Redox Signaling, 2009, 11, 7, 1569

    CrossRef

  31. 31
    Ines Armando, Van Anthony M. Villar, Pedro A. Jose, Dopamine and Renal Function and Blood Pressure Regulation, Comprehensive Physiology,
  32. 32
    Valentin K. Gribkoff, Neuronal Mitochondria as a Target for the Discovery and Development of New Therapeutics,